Do Angiotensin Receptor Blockers reduce fibrosis and Interleukin-6 expression in Calcific Aortic Valve Disease?
ARBs may alter the fibrotic process of the aortic valve in CAVD, possibly by lowering tissue inflammation.
These findings suggest that ARBs may alter the fibrotic process of the aortic valve in CAVD, possibly by lowering tissue inflammation.
Côté et al. (Wed,) studied this question.